Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeltje Steeghs

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Annals of Surgical Oncology|November 15, 2006
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developmentsNeeltje Steeghs, Johan W R Nortier, Hans Gelderblom
Nederlands Tijdschrift Voor Geneeskunde|July 24, 2014
[A woman with purple-red nodules in an oedematous arm]Carolien H Smorenburg, Marianne B Crijns, Neeltje Steeghs
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Individualized Pazopanib Dosing-ResponseRemy B Verheijen, Alwin D R Huitema, Neeltje Steeghs
BMC Cancer|December 5, 2018
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levelsStefanie L Groenland, Daniela Katz, Alwin D R Huitema, et al.
Frontiers in Oncology|October 3, 2022
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?Alaa Embaby, Lisanne van Merendonk, Neeltje Steeghs, et al.
Investigational New Drugs|November 21, 2022
A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumorsNeeltje Steeghs, Melinda Pruis, Carla van Herpen, et al.
Biomedical Chromatography : BMC|March 14, 2025
Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital-Based Towards Home-SamplingMarinda Meertens, Hilde Rosing, Neeltje Steeghs, et al.
Future Oncology (London, England)|February 7, 2020
Encorafenib, binimetinib and cetuximab combined therapy for patients with <i>BRAFV600E</i> mutant metastatic colorectal cancerSanne Cfa Huijberts, Robin Mjm van Geel, Rene Bernards, et al.
Biomedical Chromatography : BMC|January 8, 2026
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug ConjugatesPauline L M Buitelaar, Hilde Rosing, Jos H Beijnen, et al.
Nature Genetics|November 20, 2019
The mutational footprints of cancer therapiesOriol Pich, Ferran Muiños, Martijn Paul Lolkema, et al.
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Annals of Surgical Oncology|November 15, 2006
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developmentsNeeltje Steeghs, Johan W R Nortier, Hans Gelderblom
Nederlands Tijdschrift Voor Geneeskunde|July 24, 2014
[A woman with purple-red nodules in an oedematous arm]Carolien H Smorenburg, Marianne B Crijns, Neeltje Steeghs
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Individualized Pazopanib Dosing-ResponseRemy B Verheijen, Alwin D R Huitema, Neeltje Steeghs
BMC Cancer|December 5, 2018
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levelsStefanie L Groenland, Daniela Katz, Alwin D R Huitema, et al.
Frontiers in Oncology|October 3, 2022
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?Alaa Embaby, Lisanne van Merendonk, Neeltje Steeghs, et al.
Investigational New Drugs|November 21, 2022
A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumorsNeeltje Steeghs, Melinda Pruis, Carla van Herpen, et al.
Biomedical Chromatography : BMC|March 14, 2025
Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital-Based Towards Home-SamplingMarinda Meertens, Hilde Rosing, Neeltje Steeghs, et al.
Future Oncology (London, England)|February 7, 2020
Encorafenib, binimetinib and cetuximab combined therapy for patients with <i>BRAFV600E</i> mutant metastatic colorectal cancerSanne Cfa Huijberts, Robin Mjm van Geel, Rene Bernards, et al.
Biomedical Chromatography : BMC|January 8, 2026
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug ConjugatesPauline L M Buitelaar, Hilde Rosing, Jos H Beijnen, et al.
Nature Genetics|November 20, 2019
The mutational footprints of cancer therapiesOriol Pich, Ferran Muiños, Martijn Paul Lolkema, et al.
Pageof 21